Benjamin B. Kasten
Papers
1
Total Citations
15
H-Index
1
About
Benjamin B. Kasten is a pioneering researcher in molecular imaging and surgical oncology, with a primary focus on improving outcomes for patients with oropharyngeal squamous cell carcinoma (OPSCC). His most notable contribution is the development and clinical application of targeted fluorescence-guided surgery using panitumumab-IRDye800CW, a near-infrared imaging agent that binds to EGFR-overexpressing tumors. In his landmark 2024 interim Phase II study, Kasten demonstrated how this technique enhances tumor visualization during transoral robotic surgery (TORS), overcoming the tactile limitations of robotic procedures. His work addresses the critical challenge of achieving complete tumor resection while preserving healthy tissue, directly impacting the rising incidence of OPSCC. With 15 citations already for this recent publication, Kasten's research is gaining rapid recognition for its translational potential. His achievements include advancing the field of image-guided surgery, bridging the gap between preclinical molecular imaging and real-time intraoperative decision-making. For students and researchers, Kasten exemplifies how integrating targeted imaging agents with robotic surgical platforms can redefine precision oncology, offering a compelling model for translating molecular diagnostics into tangible surgical benefits.
Research Focus
Key Achievements
Top Papers
- 1